A PLS-based extractive spectrophotometric method for simultaneous determination of carbamazepine and carbamazepine-10,11-epoxide in plasma and comparison with HPLC.
Carbamazepine (CBZ) undergoes enzyme biotransformation through epoxidation with the formation of its metabolite, carbamazepine-10,11-epoxide (CBZE). A simple chemometrics-assisted spectrophotometric method has been proposed for simultaneous determination of CBZ and CBZE in plasma. A liquid extraction procedure was operated to separate the analytes from plasma, and the UV absorbance spectra of the resultant solutions were subjected to partial least squares (PLS) regression. The optimum number of PLS latent variables was selected according to the PRESS values of leave-one-out cross-validation. A HPLC method was also employed for comparison. The respective mean recoveries for analysis of CBZ and CBZE in synthetic mixtures were 102.57 (+/-0.25)% and 103.00 (+/-0.09)% for PLS and 99.40 (+/-0.15)% and 102.20 (+/-0.02)%. The concentrations of CBZ and CBZE were also determined in five patients using the PLS and HPLC methods. The results showed that the data obtained by PLS were comparable with those obtained by HPLC method.
Hemmateenejad
Bahram
B
Department of Chemistry, Shiraz University, Shiraz, Iran. hemmatb@sums.ac.ir
Rezaei
Zahra
Z
Khabnadideh
Soghra
S
Saffari
Maryam
M
D000328:Adult; D002138:Calibration; D002220:Carbamazepine / Q000031:analogs & derivatives* / Q000097:blood / Q000737:chemistry; D002851:Chromatography, High Pressure Liquid; D006801:Humans; D016018:Least-Squares Analysis; D008875:Middle Aged; D013056:Spectrophotometry, Ultraviolet / Q000379:methods*
D002220:Carbamazepine; C012227:carbamazepine epoxide